Subscribe

Treating Patients with Acquired TKI Resistance

ASCO, ASCO 2016 – Lung Cancer
Videos — July 6, 2016

Featuring:

Benjamin P. Levy, MD, provides an overview of evolving strategies to manage patients with acquired TKI resistance in advanced non–small-cell lung cancer with a focus on identifying and treating t790m.

Related Articles

De-escalating Chemotherapy Possible in Low-Risk Patients with Advanced Testicular Cancer
By Wayne Kuznar
ASCO, Genitourinary Cancers
April 2020, Vol 11, No 2
Read Article
A Call to Focus on Financial Toxicity and Quality of Life in Genitourinary Malignancies
By Wayne Kuznar
ASCO, Genitourinary Cancers
April 2020, Vol 11, No 2
Read Article
MicroRNAs Have Promise as Biomarker in Testicular and Other Germ-Cell Tumors
By Wayne Kuznar
ASCO, Genitourinary Cancers
April 2020, Vol 11, No 2
Read Article

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
© Amplity Health. All Rights Reserved. Privacy Policy.